Literature DB >> 25797084

American College of Foot and Ankle Surgeons' clinical consensus statement: risk, prevention, and diagnosis of venous thromboembolism disease in foot and ankle surgery and injuries requiring immobilization.

Adam E Fleischer1, Bradley P Abicht1, Jeffrey R Baker1, Troy J Boffeli1, Daniel C Jupiter1, Valerie L Schade1.   

Abstract

The purpose of this document is to provide guidance for physicians regarding the risk, prevention, and diagnosis of venous thromboembolism disease after foot and ankle surgery and while caring for lower extremity injuries that require ankle immobilization. A panel composed of all authors of this document reviewed the published evidence and, through a series of meetings, reached consensus regarding the viewpoints contained herein. We conclude that routine chemical prophylaxis is not warranted; rather, patients should be stratified and have a prevention plan tailored to their individual risk level. An effective venous thromboembolism prevention program is typically multimodal and focuses on addressing any modifiable risk factors, use of mechanical prophylaxis, early mobilization, and careful consideration of the use of chemical prophylaxis. The final decision regarding use and method(s) of prophylaxis adopted should be agreed upon by both the clinician and patient after a discussion of the potential benefits and harms as they relate to the individual. This should take place preferably during the preoperative visit or in the immediate post-injury setting, and it may need to be revisited during the course of care if the patient's risk level changes. Prompt recognition of the signs and symptoms of deep venous thrombosis following surgery or injury is important. Patients suspected of deep venous thrombosis should receive further work-up with either a D-dimer test or duplex venous ultrasound of the symptomatic leg, depending on their pretest probability for the disease. The latter can be determined using a validated clinical decision-making tool (e.g., Well's criteria).
Copyright © 2015 American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ankle; deep venous thrombosis; diagnosis; foot; injury; prevention; prophylaxis; surgery

Mesh:

Year:  2015        PMID: 25797084     DOI: 10.1053/j.jfas.2015.02.022

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  6 in total

1.  Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.

Authors:  Abdullah Pandor; Daniel Horner; Sarah Davis; Steve Goodacre; John W Stevens; Mark Clowes; Beverley J Hunt; Tim Nokes; Jonathan Keenan; Kerstin de Wit
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

2.  Risk factors for venous thromboembolism following fractures isolated to the foot and ankle fracture.

Authors:  Michael J Gouzoulis; Peter Y Joo; Alexander J Kammien; William M McLaughlin; Brad Yoo; Jonathan N Grauer
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

3.  Qualitative analysis of randomized controlled trials informing recommendations for venous thromboembolism prophylaxis after distal lower extremity injuries.

Authors:  Aaron J Folsom; Michael M Polmear; John P Scanaliato; John C Dunn; Adam H Adler; Justin D Orr
Journal:  OTA Int       Date:  2022-03-18

4.  Prophylaxis of Venous Thromboembolism in Ankle and Foot Surgeries.

Authors:  Roberto Zambelli; Marcos de Bastos; Suely Meireles Rezende
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2020-09-25

Review 5.  Characteristics of Deep Venous Thrombosis in Isolated Lower Extremity Fractures and Unsolved Problems in Guidelines: A Review of Recent Literature.

Authors:  Wei-Guang Zhao; Wei-Li Zhang; Ying-Ze Zhang
Journal:  Orthop Surg       Date:  2022-05-27       Impact factor: 2.279

6.  Cost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty.

Authors:  Brandon J Martinazzi; Gregory J Kirchner; Christopher M Stauch; F Jeffrey Lorenz; Kristen M Manto; Vincenzo Bonaddio; Zachary Koroneos; Michael C Aynardi
Journal:  Foot Ankle Int       Date:  2022-07-28       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.